作为抗癌治疗的标,乌比基蛋白酶系统 - - 一个最新的更新
Yeon Jung Kim1, Yeonjoo Lee1, Hyungkyung Shin1
1College of Pharmacy, Ewha Womans University, 52, Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, Republic of Korea.
Archives of pharmacal research
|August 4, 2023
概括
无素蛋白酶体系统 (UPS) 在细胞调节和癌症中至关重要. 新的UPS成分抑制剂,包括E3结合酶和二维基提纳酶,显示出作为新型抗癌疗法的前景.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 无素蛋白酶体系统 (UPS) 调节了重要的生物过程.
- UPS 组件的调节失调与各种病理有关,特别是癌症.
- 蛋白酶体抑制剂,如博尔特佐米布,是已知的抗癌药物.
研究的目的:
- 审查新的UPS组件及其在瘤发生中的作用.
- 探索UPS成分抑制剂在癌症治疗中的治疗潜力.
- 讨论克服对现有的蛋白酶体抑制剂耐药性的策略.
主要方法:
- 关于UPS组件的最新发现的文献综述.
- 对UPS抑制剂的机制和临床试验数据的分析.
- 检查新兴的治疗策略,如PROTACs.
主要成果:
- 新发现的UPS组件 (E3结合酶,DUB,免疫蛋白酶) 与癌症有关.
- 几种新的UPS抑制剂正在进行抗癌治疗的临床研究.
- 在癌症中,PROTAC技术提供了一种针对UPS的新方法.
结论:
- 针对UPS组件是新型癌症治疗的有希望的策略.
- 了解UPS机制是开发有效和克服耐药性的治疗方法的关键.
- 新兴的UPS准工具,如PROTAC,具有显著的治疗潜力.
相关概念视频
The Proteasome
892
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
892
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Regulated Protein Degradation
7.4K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.4K
Covalently Linked Protein Regulators
6.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.9K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


